FindTrial
Sign In

Prognostic and predictive role of TIL in locally advanced upper tract urothelial carcinoma: a retrospective, multicenter study (TSU-02 study)

Prognostic and predictive role of TIL in locally advanced upper tract urothelial carcinoma: a retrospective, multicenter study (TSU-02 study)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030308
Enrollment
Unknown
Registered
2020-02-28
Start date
2020-05-25
Completion date
Unknown
Last updated
2020-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Tract Urothelial Carcinoma

Interventions

TIL>50% vs TIL<50%:N/A

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Aged 18 years and older; (2) RNU performed between the year 2006 and 2017; (3) Disease in the renal pelvis or ureter; predominant urothelial carcinoma histology; (4) Locally advanced disease, defined as >= pT3 and/or pN1–3 (according to the local pathology report); (5) Without missing of clinical, pathological or follow-up information.

Exclusion criteria

Exclusion criteria: (1) Distant metastasis; (2) History of other malignant tumor; (3) History of neoadjuvant chemotherapy; (4) Missing of clinical, pathological or follow-up information; (5) The other condition that is not suitable to participate in this study by the researchers

Design outcomes

Primary

MeasureTime frame
Cancer-Specific Survival;—

Secondary

MeasureTime frame
Relapse-Free Survival;Disease-Free Survival;—

Countries

China

Contacts

Public ContactZhou Liqun

Peking University First Hospital

zhoulqmail@sina.com+86 13601239241

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026